The Innovation | Virtual Collection—Stop COVID-19 (v3) 新冠专辑3.0

Figure 1 Summary of Publishing (2020—2022)

图1 出版概览(2020—2022年)

Introduction

The Innovation has published 300 articles from 2020 to 2022 (Figure 1).  The authors come from 49 countries and articles belong to 9 categories (Figure 2), which have been cited by researchers from 113 countries (Source: Web of Science). The Innovation is a multidisciplinary journal covering all natural science fields. To facilitate readers to refer to articles in a specific field, Editorial Team integrates the contents from different Issues to make this Virtual Collection. 

引言

从2020到2022，The Innovation出版三卷十三期共300篇文章（图1），作者来自49个国家。这些文章分布在9个栏目（图2），已被113个国家作者引用（数据源: Web of Science）。The Innovation是综合性英文期刊，发文内容涵盖所有自然科学领域。为方便读者查看出版的某领域文章，编辑部整合这两年不同刊次的相关内容，陆续推送Virtual Collection（虚拟专辑）……在本刊发表的文章，同时在微信公众号上进行“科普化解读”——尽可能让更多人懂得文章的主旨和亮点：传播科学知识，传承科学素养；和您一起理解科技创新的最新进展与突破！2020年-2021年，出版周期为季刊；2022年-2023年，出版周期为双月刊（出版月份：1/3/5/7/9/11）

Figure 2 Categories of Publishing (2020—2022)

图2 文章全貌(2020—2022年)

About Stop COVID-19 (v3) 

新冠专辑3.0

SARS-CoV-2: It infected > 650 million people and killed > 6.68 million people worldwide, casting a lingering shadow on human society. With the joint efforts of scientists and medical experts, various vaccines and treatment schemes have been launched one after another... In this global pandemic, we firmly believe that only scientific and technological development can break through the darkness. Under the sustainable development goals of United Nations, we hope that the whole world will become better and better through the humanity efforts together.

新冠病毒：它已造成全球6.5亿人感染，668万人死亡，给人类社会投下挥之不去的阴影。在科学家和医学家等的共同努力下，各类疫苗和治疗方案陆续面世……在这场“战疫”中，我们坚信唯有科学的发展，技术的创新，才是冲破黑暗的光亮。祈愿这个世界在可持续发展的理念指导下，变得越来越美好。本次虚拟专辑收录与COVID-19相关的Editorial 3篇，Article 4篇，Report 13篇，Review 3篇，Commentary 28篇，News & Buzz 3篇；共计54篇。

 Section 1

Editorials

Collaboration in the War against Viruses: A Multidisciplinary International Effort

To manage long COVID by selective SARS-CoV-2 infection biosensing.

Bioassay development for public health emergency

Section 2 

Articles

Predictive Model and Risk Factors for Case Fatality of COVID-19: A Cohort of 21,392 Cases in Hubei, China

Urban Air Pollution May Enhance COVID-19 Case-Fatality and Mortality Rates in the United States

Daily CO₂ Emission Reduction Indicates the Control of Activities to Contain COVID-19 in China

Host-specific asymmetric accumulation of mutation types reveals that the origin of SARS-CoV-2 is consistent with a natural process

 Section 3

Reports

Epidemiological and Clinical Characteristics of COVID-19 in Adolescents and Young Adults

Predicting Illness Severity and Short-term Outcomes of COVID-19: A Retrospective Cohort Study in China

Modeling the Prevalence of Asymptomatic COVID-19 Infections in the Chinese Mainland

Early Research on COVID-19: A Bibliometric Analysis

Laboratory diagnosis and monitoring the viral shedding of SARS-CoV-2 infection

Contribution of Temperature Increase to Restrain the Transmission of COVID-19

Structural basis of SARS-CoV-2 polymerase inhibition by Favipiravir

Phylogenomic tracing of asymptomatic transmission in a COVID-19 outbreak

Assessing the extent of community spread caused by mink-derived SARS-CoV-2 variants

Ambient air pollution and low temperature associated with case fatality of COVID-19: A nationwide retrospective cohort study in China

A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates

Antibody neutralization to SARS-CoV-2 and variants after one year in Wuhan, China

A highly immunogenic live-attenuated vaccine candidate prevents SARS-CoV-2 infection and transmission in hamsters

 Section 4

Reviews

Genomic variation, origin tracing and vaccine development of SARS-CoV-2: A systematic review

Delineating COVID-19 immunological features using single-cell RNA sequencing

Co-existence and co-infection of influenza A viruses and coronaviruses: public health challenges

 Section 5

Commentaries

What is Required to Prevent a Second Major Outbreak of SARS-CoV-2 upon Lifting Quarantine of Wuhan City, China?

Differentiating COVID-19 Response Strategies

New Virus, New Challenge

Achieving Positive Mental Health and Wellbeing on the COVID-19 Frontline

Patients' Attitudes to Unproven Therapies in Treating Covid-19 Merit Evaluation

Culture versus Policy: More Global Collaboration to Effectively Combat COVID-19

Modeling the COVID-19 Outbreak in China through Multi-source Information Fusion

Accelerate the Promotion of Mobile Payments during the COVID-19 Epidemic

Modelling the epidemic trend of the 2019 novel coronavirus outbreak in China

Characteristics analysis and implications on the COVID-19 reopening of Victoria, Australia

Recovery of Four COVID-19 Patients via Ozonated Autohemotherapy

Tackling COVID-19 in Africa: A Focus on Nigeria's Peculiarities and Challenges

Mass testing - an underexplored strategy for COVID-19 control

Genetic correlations between COVID-19 and a variety of traits and diseases

Climate change, environmental factors, and COVID-19: Current evidence and urgent actions 

2019nCoVR—A comprehensive genomic resource for SARS-CoV-2 variant surveillance

Mechanism of action of favipiravir against SARS-CoV-2: Mutagenesis or chain termination?

Rapid and accurate identification of SARS-CoV-2 variants containing E484 mutation

Four-month intrinsic viral cycle in COVID-19

The mysterious origins of the Omicron variant of SARS-CoV-2

Is Omicron variant of SARS-CoV-2 coming to an end?

A four-month cycle in COVID-19 cases in Switzerland

Why is the SARS-CoV-2 Omicron variant milder?

Global impacts of COVID-19 on sustainable ocean development

Excess mortality rather than case fatality rate is a superior indicator to assess the impact of COVID-19 pandemic

Inhalable antibodies for the treatment of COVID-19

From Animal to Human: Interspecies Analysis Provides a Novel Way of Ascertaining and Fighting COVID-19

扫二维码｜查看原文

原文链接：https://www.cell.com/the-innovation/fulltext/S2666-6758(20)30021-7

The sound of host-SARS-CoV-2 molecular interactions

扫二维码｜查看原文

原文链接：https://www.cell.com/the-innovation/fulltext/S2666-6758(21)00051-5

Section 6 

News & Buzz

Zoonotic attack: An underestimated threat of SARS-CoV-2?

Omicron XE emerges as SARS-CoV-2 keeps evolving

The first Chinese oral anti-COVID-19 drug Azvudine launched

期刊简介

扫二维码 ｜ 关注期刊官微

The Innovation是一本由青年科学家与Cell Press于2020年共同创办的综合性英文学术期刊：向科学界展示鼓舞人心的跨学科发现，鼓励研究人员专注于科学的本质和自由探索的初心。作者来自全球49个国家；已被113个国家作者引用；每期1/4-1/3通讯作者来自海外。目前有195位编委会成员，来自21个国家；50%编委来自海外；包含1位诺贝尔奖获得者，33位各国院士；领域覆盖全部自然科学。The Innovation已被DOAJ，ADS，Scopus，PubMed，ESCI，INSPEC等数据库收录。秉承“好文章，多宣传”理念，The Innovation在海内外各平台推广作者文章。

期刊官网1（Owner）：

www.the-innovation.org

期刊官网2（Publisher）：

www.cell.com/the-innovation/home

期刊投稿（Submission）：

www.editorialmanager.com/the-innovation

商务合作（Marketing）：

marketing@the-innovation.org

Logo｜期刊标识

See the unseen & change the unchanged

创新是一扇门，我们探索未知；  

创新是一道光，我们脑洞大开；  

创新是一本书，我们期待惊喜；  

创新是一个“1”，我们一路同行。